Literature DB >> 20160970

Synthesis of α-carboranyl-α-acyloxy-amides as potential BNCT agents.

Subash C Jonnalagadda1, Jonathan S Cruz, Ryan J Connell, Patricia M Scott, Venkatram R Mereddy.   

Abstract

Novel α-carboranyl-α-acyloxy-amides were prepared as potential BNCT agents utilizing three component Passerini reaction. Preliminary cytotoxicity of the representative compounds on two brain tumor cell lines (U-87 and A-172) showed no effect on cell viability; an essential requirement for utility as potential BNCT agents.

Entities:  

Year:  2009        PMID: 20160970      PMCID: PMC2760853          DOI: 10.1016/j.tetlet.2009.05.026

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  The Chemistry of Neutron Capture Therapy.

Authors:  Albert H. Soloway; Werner Tjarks; Beverly A. Barnum; Feng-Guang Rong; Rolf F. Barth; Iwona M. Codogni; J. Gerald Wilson
Journal:  Chem Rev       Date:  1998-06-18       Impact factor: 60.622

2.  Synthesis of functionalized carboranes as potential anticancer and BNCT agents.

Authors:  Venkata Jaganmohan Reddy; Matthew M Roforth; Chalet Tan; M Venkat Ram Reddy
Journal:  Inorg Chem       Date:  2007-01-22       Impact factor: 5.165

3.  Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains.

Authors:  Fars Alanazi; Hengguang Li; David S Halpern; Svein Øie; D Robert Lu
Journal:  Int J Pharm       Date:  2003-04-14       Impact factor: 5.875

4.  Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.

Authors:  Jong-Dae Lee; Manabu Ueno; Yusuke Miyajima; Hiroyuki Nakamura
Journal:  Org Lett       Date:  2007-01-18       Impact factor: 6.005

Review 5.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.

Authors:  L Maletínská; E A Blakely; K A Bjornstad; D F Deen; L J Knoff; T M Forte
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  Catalytic phenylborylation reaction by iridium(0) nanoparticles produced from hydridoiridium carborane.

Authors:  Zhu Yinghuai; Koh Chenyan; Ang Thiam Peng; A Emi; Winata Monalisa; Loo Kui-Jin Louis; Narayan S Hosmane; John A Maguire
Journal:  Inorg Chem       Date:  2008-05-31       Impact factor: 5.165

Review 8.  Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.

Authors:  Gong Wu; Rolf F Barth; Weilian Yang; Robert J Lee; Werner Tjarks; Marina V Backer; Joseph M Backer
Journal:  Anticancer Agents Med Chem       Date:  2006-03       Impact factor: 2.505

Review 9.  Antibody-modified liposomes for cancer chemotherapy.

Authors:  Vladimir Torchilin
Journal:  Expert Opin Drug Deliv       Date:  2008-09       Impact factor: 6.648

10.  In vitro uptake of a new cholesteryl carborane ester compound by human glioma cell lines.

Authors:  Gina Peacock; Richard Sidwell; Guangliang Pan; Svein Øle; D Robert Lu
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

View more
  2 in total

1.  Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents.

Authors:  Mohammad A Alam; Kriti Arora; Shirisha Gurrapu; Sravan K Jonnalagadda; Grady L Nelson; Paul Kiprof; Subash C Jonnalagadda; Venkatram R Mereddy
Journal:  Tetrahedron       Date:  2016-03-17       Impact factor: 2.457

2.  Therapeutic potential of atmospheric neutrons.

Authors:  Cyril Voyant; Rudy Roustit; Jennifer Tatje; Katia Biffi; Delphine Leschi; Jérome Briançon; Céline Lantieri Marcovici
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.